Status and phase
Conditions
Treatments
About
Recently, a special emphasis has recently been directed to the potential role of vitamin D and some regulatory peptides (e.g. adipokines and follistatin) and their associated metabolic roles and genetic factors in the development of PCOS and its related co-morbidities. The aim of this study was to assess the feasibility of conducting a pragmatic RCT assessing the effectiveness of adopting a protocol of screening for and correcting Vitamin D deficiency in women with PCOS seeking fertility treatment in a low/middle income care (LMIC) setting
Full description
Research question:
In PCOS patients, is there any effect of vitamin D testing and correction on ovulation induction in women with PCOS?
Research hypothesis:
There is effect of testing and correcting vitamin D status as regard ovulation in patients with PCOS
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1- PCOS patients not in child bearing age; less than 18 years or more than 45 years.
2- Patients with congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia and virilizing ovarian or adrenal tumors.
3- PCOS patients with any other medical illness. 4- PCOS patients already on vitamin D supplements.
Primary purpose
Allocation
Interventional model
Masking
300 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal